Economics of polio vaccination in the post-eradication era: Should OPV-using countries adopt IPV?

Vaccine

Volumn 26, Issue 16, 2008, Pages 2034-2040

  Khan, M Mahmud ^a  

^a TULANE UNIVERSITY   (United States)

Author keywords

Polio immunisation; Post certification era; Vaccination costs

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; ERADICATION THERAPY; HUMAN; POLIOMYELITIS; PRIORITY JOURNAL; VACCINATION;

CHILD; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; POLICY MAKING; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; VACCINATION; WORLD HEALTH;

EID: 40849094113     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.02.008     Document Type: Article

References (20)

1. World Health Organization, Polio case count, Global summary, from website http://www.who.int/immunization_monitoring/en/diseases/poliomyelitis/case_count.cfm.
2. World Health Organization, Resurgence of wild poliovirus type 1 transmission and effect of importation into polio-free countries, 2002-2005. Wkly Epidemiol Rec 2006;81(7):63-8.
3. Kew O.M., Wright P.F., Agol V.I., Delpeyroux F., Shimizu H., Nathanson N., et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 82 1 (2004) 16-23
4. Duintjer Tebbens R.J., Pallansch M.A., Kew O.M., Caceres V.M., Sutter R.W., and Thompson K.M. A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future. Am J Epidemiol 162 4 (2005) 358-372
5. World Health Organization. Global Polio Eradication Initiative Strategic Plan 2004-2008; 2003. Available at http://www.polioeradication.org/content/publications/2004stratplan.pdf.
6. Sutter R.W., Caceres V.M., and Mas Lago P. The role of routine polio immunization in the post-certification era. Bull World Health Organ 82 1 (2004) 31-39
7. World Health Organization. Cessation of routine oral polio vaccine (OPV) use after global polio eradication: framework for national policy makers in OPV-using countries. Geneva; 2005 (WHO/POLIO/05.02).
8. Government of India, India Expert Advisory Group (IEAG), 14th IEAG Presentation. IEAG Findings, Delhi, India, December 5-6, 2005.
9. World Health Organization. Global burden of disease 2000, U013 Poliomyelitis, http://www.who.int/.
10. Bart K.J., Foulds J., and Patriarca P. Global eradication of poliomyelitis: benefit-cost analysis. Bull World Health Organ 74 1 (1996) 35-45
11. Khan M.M., and Ehreth J. Costs and benefits of polio eradication: a long-run global perspective. Vaccine 21 7-8 (2003) 702-705
12. Sangrujee N., Caceres V.M., and Cochi S.L. Cost analysis of post-polio certification immunization policies. Bull World Health Organ 82 1 (2004) 9-15
13. Liu X., Levin A., Makinen M., and Day J. OPV and IPV: past and future choice of vaccine in the global polio eradication program (February 2002), The Partners in Health Reform Plus Project, Abt Associates Inc., Bethesda, MD
14. Khan MM, Yoder RA. Expanded Program on immunization in Bangladesh: cost, cost-effectiveness, and financing estimates. Technical Report number 24. Bethesda, MD: The Partners in Health Reform Project, Abt Associates Inc.; September 1998.
15. Kaddar M, Levin A, Dougherty L, Maceira D. Costs and financing of immunization programs: findings of four case studies. Special initiatives report no. 26. Bethesda, MD: The Partners in Health Reform Project, Abt Associates Inc.; May 2000.
16. Brenzel L., and Claquin P. Immunization programs and their costs. Soc Sci Med 39 4 (1994) 527-536
17. Jian Z., Jing-jin Y., Rong-zhen Z., Xing-lu Z., Jun Z., Wing J.S., et al. Costs of polio immunization days in China: implications for mass immunization campaign strategies. Int J Health Plann Mgmt 13 (1998) 5-25
18. Kaddar M, Mookherji S, DeRoeck D, Antona D. Case study on the costs and financing of immunization services in Morocco. Special initiatives report number 18. Bethesda, MD: The Partners in Health Reform Project, Abt Associates Inc.; May 2000.
19. Musgrove P. Is polio eradication in the Americas economically justified?. Health Economics: Latin American Perspectives (1989), Pan American Health Organization. Scientific publication no. 517
20. Lieu T., Thompson K.M., Prosser L.A., O'Brien M.A., Yusuf H.R., Shefer A.M., et al. Emerging issues in vaccine economics: perspectives from the USA. Exp Rev Vac 1 4 (2002) 433-442